{"id":28,"date":"2012-03-08T20:28:55","date_gmt":"2012-03-08T11:28:55","guid":{"rendered":"http:\/\/urology.dept.med.gunma-u.ac.jp\/?p=28"},"modified":"2018-08-27T10:56:01","modified_gmt":"2018-08-27T01:56:01","slug":"2007paper","status":"publish","type":"post","link":"https:\/\/urology.dept.med.gunma-u.ac.jp\/?p=28","title":{"rendered":"2007\u5e74"},"content":{"rendered":"
    \n
  1. Ito K, Yamamoto T, Miyakubo M, Takechi H, Ohi M, Shibata Y and Suzuki K: Lead time of prostate cancer detected in population based screening for prostate cancer in Japan. J Urol; 178:1258-1264, 2007.<\/li>\n
  2. Ito K: Editorial comment:factor that influence serum prostate-specific antigen levels in terms of maintaining quality within a PSA screening system. Eur Urol; 52(3):714, 2007.<\/li>\n
  3. Ito K: Editorial comment:RE:Prostate cancer risk assessment program: a 10-year update of cancer detection. J Urol; 178:1924, 2007.<\/li>\n
  4. Sekine Y, Koike H, Nakano T, Nakajima K and Suzuki K: Remnant lipoproteins stimulate proliferation and activete MARK and Akt signaling pathways via G protein-coupled receptor in PC-3 prostate cancer cells. Clin Chem Acta; 383(1-2):78-84, 2007.<\/li>\n
  5. Sekine Y, Ito K, Yamamoto T, Nakazato H, Shibata Y, Hatori M and Suzuki K: Pretreatment total testosterone levels in patients with prostate cancer in the past two decades in Japan. Cancer Detect Prev; 31(2):149-153, 2007.<\/li>\n
  6. Kobayashi T, Goto R, Ito K and Mitsumori K: Prostate cancer screening strategies with re-screening interval determined by individual baseline prostate-specific antigen values are cost-effective. Eur J Surg Oncol; 33(6):783-789, 2007.<\/li>\n
  7. Mizokami A, Ueno S, Fukagai T, Ito K, Ehara H, Kinbara H, Origasa H, Usami M, Namiki M and Akaza H:Global update on defining and treating high-risk localized prostate cancer with leuprorelin: an Asian perspective. BJU Int; 99(suppl 1):6-9, 2007.<\/li>\n
  8. \u4f0a\u85e4\u4e00\u4eba\uff1a\u60aa\u6027\u816b\u760d\u304a\u3088\u3073\u304c\u3093\u75bc\u75db\u300014-5)\u524d\u7acb\u817a\u764c. \u85ac\u5c40\u5897\u520a\u53f7\uff62\u75c5\u6c17\u3068\u85ac\u306e\u8aac\u660e\u30ac\u30a4\u30c92007\uff63; 58(4):1759-1772, 2007.<\/li>\n
  9. \u4f0a\u85e4\u4e00\u4eba\u3001\u5c71\u672c\u3000\u5de7\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u9234\u6728\u548c\u6d69\uff1a\u30c8\u30d4\u30c3\u30af\u30b9\u300ctotal PSA\u306e\u5e74\u9f62\u5225\u57fa\u6e96\u5024\u300d. \u691c\u67fb\u3068\u6280\u8853; 35(5):501-503, 2007.<\/li>\n
  10. \u4f0a\u85e4\u4e00\u4eba\uff1a\u7b2c5\u7ae0 \u8a3a\u65ad\uff1aPSA\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0. \u6700\u65b0\u533b\u5b66\u5225\u518a \u65b0\u3057\u3044\u8a3a\u65ad\uff65\u6cbb\u7642\u306eABC\u30b7\u30ea\u30fc\u30ba\uff62\u524d\u7acb\u817a\u764c\uff63; pp.50-57, 2007.<\/li>\n
  11. \u4f0a\u85e4\u4e00\u4eba\uff1a\u524d\u7acb\u817a\u691c\u8a3a\u5354\u8b70\u4f1a\u904b\u55b6\u59d4\u54e1\u4f1a\u30fb\u524d\u7acb\u817a\u304c\u3093\u64b2\u6ec5\u63a8\u9032\u59d4\u54e1\u4f1a\u5408\u540c\u4f1a\u8b70\u8a18\u9332\u96c6
    \n2.\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u7cbe\u5ea6\u7ba1\u7406\u4e8b\u696d\u3068\u5730\u57df\u304c\u3093\u767b\u9332\u4e8b\u696d\u306e\u30c7\u30fc\u30bf\u5171\u6709\u30b7\u30b9\u30c6\u30e0. \u6ccc\u5c3f\u5668\u5916\u79d1; 20(8):1125-1128, 2007.<\/li>\n
  12. \u4f0a\u85e4\u4e00\u4eba\uff1aTOPICS PSA\u306b\u3088\u308b\u524d\u7acb\u817a\u764c\u306e\u8a3a\u65ad. \u9031\u520a\uff62\u533b\u5b66\u306e\u3042\u3086\u307f\uff63; 223(3):251-252, 2007.<\/li>\n
  13. \u4f0a\u85e4\u4e00\u4eba\uff1a\u2160.\u7dcf\u8ad6 2.\u4e3b\u8981\u75c7\u5019\u30fb\u691c\u67fb\u304b\u3089\u8a3a\u65ad\u3078\u306e\u30a2\u30d7\u30ed\u30fc\u30c1\u3000(2)\u8eab\u4f53\u5fb4\u5019\u30fb\u691c\u67fb\u304b\u3089\u814e\uff65\u5c3f\u8def\u7cfb\u75be\u60a3\u3092\u898b\u3064\u3051\u51fa\u3059\u300012)PSA\u3068\u816b\u760d\u30de\u30fc\u30ab\u30fc. \u65e5\u672c\u533b\u5e2b\u4f1a\u96d1\u8a8c\u7279\u5225\u53f7(\u751f\u6daf\u6559\u80b2\uff7c\uff98\uff70\uff7d\uff9e)\u300e\u814e\u30fb\u6ccc\u5c3f\u5668\u75be\u60a3\u8a3a\u7642\u30de\u30cb\u30e5\u30a2\u30eb\u2015\u5c0f\u5150\u304b\u3089\u6210\u4eba\u307e\u3067\u300f; 136(\u7279\u52252):S86-S87, 2007.<\/li>\n
  14. \u4f0a\u85e4\u4e00\u4eba\uff1a\u524d\u7acb\u817a\u764c\u2015\u57fa\u790e\u30fb\u81e8\u5e8a\u7814\u7a76\u306e\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u2015
    \n\u2161\u81e8\u5e8a\u7814\u7a76\u30002.\u691c\u8a3a\u30002)\u6d77\u5916\u306b\u304a\u3051\u308bPSA\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0. \u65e5\u672c\u81e8\u7240; 65(\u5897\u520a10):194-198, 2007.<\/li>\n
  15. \u4f0a\u85e4\u4e00\u4eba\uff1a\u691c\u67fb\u5024\u3092\u8aad\u307f\u89e3\u304f\u3000PSA\u306b\u3088\u308b\u524d\u7acb\u817a\u764c\u8a3a\u65ad\u30fb\u6cbb\u7642\u30b7\u30b9\u30c6\u30e0\u306e\u9032\u6b69. Laboratory and Clinical Practice; 25(2):84-88, 2007.<\/li>\n
  16. \u5927\u4e95\u3000\u52dd\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u5c71\u672c\u3000\u5de7\u3001\u6b66\u667a\u6d69\u4e4b\u3001\u9234\u6728\u548c\u6d69\uff1a\u524d\u7acb\u817a\u764c\u2015\u57fa\u790e\u30fb\u81e8\u5e8a\u7814\u7a76\u306e\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u2015
    \n\u2161\u81e8\u5e8a\u7814\u7a76\u30002.\u691c\u8a3a\u30004)\u524d\u7acb\u817a\u764c\u691c\u8a3a\u306b\u304a\u3051\u308b\u5e74\u9f62\u968e\u5c64\u5225PSA\u57fa\u6e96\u5024\u5c0e\u5165\u306e\u610f\u7fa9. \u65e5\u672c\u81e8\u7240; 65(\u5897\u520a10):203-206, 2007.<\/li>\n
  17. \u5927\u7af9\u4f38\u660e\u3001\u4e2d\u7530\u8aa0\u53f8\u3001\u9234\u6728\u548c\u6d69\u3001\u6df1\u5800\u80fd\u7acb\u3001\u5c71\u4e2d\u82f1\u58fd\uff1a\u524d\u7acb\u817a\u764c\u2015\u57fa\u790e\u30fb\u81e8\u5e8a\u7814\u7a76\u306e\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u2015
    \n\u2161\u81e8\u5e8a\u7814\u7a76\u3000\u75ab\u5b66\u3000\u6211\u304c\u56fd\u306b\u304a\u3051\u308b\u5bb6\u65cf\u6027\u524d\u7acb\u817a\u764c\u306e\u7279\u5fb4. \u65e5\u672c\u81e8\u7240; 65(\u5897\u520a10):182-186, 2007.<\/li>\n
  18. \u95a2\u6839\u82b3\u5cb3\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u6b66\u4e95\u667a\u5e78\u3001\u67cf\u6728\u6587\u8535\u3001\u66f2\u3000\u53cb\u5f18\u3001\u798f\u9593\u88d5\u4e8c\u3001\u897f\u4e95\u660c\u5f18\u3001\u6ff1\u91ce\u9054\u4e5f\u3001\u5c71\u672c\u3000\u5de7\u3001\u67f4\u7530\u5eb7\u535a\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9ed2\u5ddd\u516c\u5e73\u3001\u753a\u7530\u660c\u5df3\u3001\u6797\u3000\u96c5\u9053\u3001\u9234\u6728\u548c\u6d69\uff1aBartter\u75c7\u5019\u7fa4\u306e\u5c0f\u5150\u6162\u6027\u814e\u4e0d\u5168\u60a3\u5150\u306b\u814e\u79fb\u690d\u3092\u65bd\u884c\u3057\u305f\uff11\u4f8b. \u65e5\u672c\u900f\u6790\u533b\u5b66\u4f1a\u8a8c; 40(7):623-627, 2007.<\/li>\n
  19. \u95a2\u6839\u82b3\u5cb3\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u9234\u6728\u548c\u6d69\uff1a\u524d\u7acb\u817a\u764c\u4e88\u9632\u306e\u53ef\u80fd\u6027\u3000\u8102\u8cea. \u6ccc\u5c3f\u5668\u5916\u79d1; 20(12):1525-1529, 2007.<\/li>\n
  20. \u6b66\u667a\u6d69\u4e4b\u3001\u4f0a\u85e4\u4e00\u4eba\uff1a\u524d\u7acb\u817a\u764c\u2015\u57fa\u790e\u30fb\u81e8\u5e8a\u7814\u7a76\u306e\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u2015
    \n\u2161\u81e8\u5e8a\u7814\u7a76\u30002.\u691c\u8a3a\u30005)\u524d\u7acb\u817a\u764c\u691c\u8a3a\u666e\u53ca\u306b\u4f34\u3046\u6210\u679c. \u65e5\u672c\u81e8\u7240; 65(\u5897\u520a10):207-213, 2007.<\/li>\n
  21. \u4e2d\u7530\u8aa0\u53f8\u3001\u53e4\u8c37\u6d0b\u4ecb\u3001\u84ee\u898b\u3000\u52dd\u3001\u4e2d\u91ce\u52dd\u4e5f\u3001\u9ad8\u6a4b\u6ea5\u670b\uff1aMAB\u307e\u305f\u306f\u5973\u6027\u30db\u30eb\u30e2\u30f3\u5264\u4f75\u7528\u306b\u3088\u308b\u521d\u671f\u5185\u5206\u6ccc\u7642\u6cd5\u306b\u3066\u3082PSA\u4f4e\u4e0b\u304c\u4e0d\u5341\u5206\u306a\u524d\u7acb\u817a\u764c\u75c7\u4f8b\u306e\u691c\u8a0e.\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u96d1\u8a8c; 98(7):803-807, 2007.<\/li>\n
  22. \u4e2d\u6751\u654f\u4e4b\u3001\u60a6\u6c38\u3000\u5fb9\u3001\u4f50\u3005\u6728\u9756\u3001\u65b0\u7530\u8cb4\u58eb\u3001\u5965\u6728\u5b8f\u5ef6\u3001\u5ca1\u5d0e\u3000\u6d69\u3001\u52a0\u85e4\u5ba3\u96c4\u3001\u5c71\u672c\u3000\u5de7\u3001\u9234\u6728\u548c\u6d69\uff1a\u7fa4\u99ac\u770c\u9928\u6797\u5e02\u524d\u7acb\u817a\u764c\u691c\u8a3a\u306b\u3064\u3044\u3066\u20152003\u5e74\u5ea6\u304b\u30892005\u5e74\u5ea6\u306e\uff13\u5e74\u9593\u306ePSA\u5358\u72ec\u691c\u8a3a\u7d50\u679c\u2015. \u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u96d1\u8a8c; 98(4):619-628, 2007.<\/li>\n
  23. \u7fbd\u9ce5\u57fa\u660e\u3001\u6797\u3000\u96c5\u9053\u3001\u753a\u7530\u660c\u5df3\u3001\u95a2\u539f\u54f2\u592b\u3001\u677e\u5c3e\u5eb7\u6ecb\u3001\u84ee\u898b\u3000\u52dd\u3001\u7530\u4e2d\u4fca\u4e4b\u3001\u95a2\u6839\u82b3\u5cb3\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u4e2d\u91cc\u6674\u6a39\u3001\u67f4\u7530\u5eb7\u535a\u3001\u5c71\u672c\u3000\u5de7\u3001\u66f2\u3000\u53cb\u5f18\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u5ddd\u53e3\u62d3\u4e5f\u3001\u52a0\u85e4\u96c4\u4e00\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u9234\u6728\u548c\u6d69\uff1a\u7fa4\u99ac\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\u6ccc\u5c3f\u5668\u79d1\u3067\u306e\u732e\u814e\u79fb\u690d\u306e\u81e8\u5e8a\u7684\u691c\u8a0e\uff1a20\u5e74\u9593\u306e\u6b69\u307f. Kitakanto Med J; 57(2):165-158, 2007.<\/li>\n
  24. \u7fbd\u9ce5\u57fa\u660e\u3001\u6797\u3000\u96c5\u9053\u3001\u753a\u7530\u660c\u5df3\u3001\u95a2\u539f\u54f2\u592b\u3001\u677e\u5c3e\u5eb7\u6ecb\u3001\u84ee\u898b\u3000\u52dd\u3001\u7530\u4e2d\u4fca\u4e4b\u3001\u95a2\u6839\u82b3\u5cb3\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u4e2d\u91cc\u6674\u6a39\u3001\u67f4\u7530\u5eb7\u535a\u3001\u5c71\u672c\u3000\u5de7\u3001\u66f2\u3000\u53cb\u5f18\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u5ddd\u53e3\u62d3\u4e5f\u3001\u52a0\u85e4\u96c4\u4e00\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u9234\u6728\u548c\u6d69\uff1a\u7fa4\u99ac\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\u6ccc\u5c3f\u5668\u79d1\u3067\u306e\u751f\u4f53\u814e\u79fb\u690d\u306e\u81e8\u5e8a\u7684\u691c\u8a0e\u201520\u5e74\u9593\u306e\u6b69\u307f\u2015. Kitakanto Med J; 57(3):225-230, 2007.<\/li>\n
  25. \u5bae\u4e45\u4fdd\u771f\u610f\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u6b66\u667a\u6d69\u4e4b\u3001\u5c71\u672c\u3000\u5de7\u3001\u5927\u4e95\u3000\u52dd\u3001\u9234\u6728\u548c\u6d69\uff1a\u524d\u7acb\u817a\u751f\u691c\u65b9\u6cd5\u304c\u751f\u691c\u75c5\u7406\u6240\u898b\u306b\u4e0e\u3048\u308b\u5f71\u97ff\u2015\u591a\u6570\u30ab\u6240\u751f\u691c\u6cd5\u3068\uff16\u30ab\u6240\u751f\u691c\u306e\u6bd4\u8f03\u2015. \u6ccc\u5c3f\u5668\u5916\u79d1; 20(8):978-990, 2007.<\/li>\n
  26. \u5c71\u4e2d\u82f1\u58fd\u3001\u5cf6\u5d0e\u3000\u6df3\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u5c71\u672c\u3000\u5de7\u3001\u8d64\u5009\u529f\u4e00\u90ce\uff1a\u524d\u7acb\u817a\u691c\u8a3a\u5354\u8b70\u4f1a\u904b\u55b6\u59d4\u54e1\u4f1a\u30fb\u524d\u7acb\u817a\u304c\u3093\u64b2\u6ec5\u63a8\u9032\u59d4\u54e1\u4f1a\u5408\u540c\u4f1a\u8b70\u8a18\u9332\u96c6
    \n2.\u4eba\u9593\u30c9\u30c3\u30af\u691c\u8a3a\u306b\u304a\u3051\u308b\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u5b9f\u65bd\u72b6\u6cc1\u8abf\u67fb\uff08\u5e73\u621017\u5e74\u5ea6\uff09. \u6ccc\u5c3f\u5668\u5916\u79d1; 20(8):1113-1115, 2007.<\/li>\n
  27. \u7530\u4e2d\u5553\u5e79\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u5cf6\u5d0e\u3000\u6df3\uff1a\u524d\u7acb\u817a\u691c\u8a3a\u5354\u8b70\u4f1a\u904b\u55b6\u59d4\u54e1\u4f1a\u30fb\u524d\u7acb\u817a\u304c\u3093\u64b2\u6ec5\u63a8\u9032\u59d4\u54e1\u4f1a\u5408\u540c\u4f1a\u8b70\u8a18\u9332\u96c6
    \n1.\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u7814\u7a76\u73ed(\u7530\u4e2d\u73ed)\u5e73\u621014\u5e74\u5ea6\u7d50\u679c\u5831\u544a. \u6ccc\u5c3f\u5668\u5916\u79d1; 20:1107-1112, 2007.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    Ito K, Yamamoto T, Miyakubo M, Takechi H, Ohi M, Shibata Y and Suzuki K: Lead time of prostate cancer detected […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-28","post","type-post","status-publish","format-standard","hentry","category-achievements"],"_links":{"self":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts\/28","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=28"}],"version-history":[{"count":1,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts\/28\/revisions"}],"predecessor-version":[{"id":1303,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts\/28\/revisions\/1303"}],"wp:attachment":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=28"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=28"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=28"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}